Lucioni, Carlo, Silvio Mazzi, and Roberto Caporali. “Budget Impact Analysis of Infliximab Biosimilar: the Italian Scenery: Analisi Di Budget Impact Del Biosimilare Di Infliximab: Lo Scenario Italiano”. Global and Regional Health Technology Assessment 2, no. 2 (October 7, 2015): 78–88. Accessed July 3, 2024. https://journals.aboutscience.eu/index.php/grhta/article/view/330.